Ovid Therapeutics (OVID) News
NASDAQ: OVIDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.46+0.12 (+5.13%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
OVID news summary
We found 1 recent headline mentioning Ovid Therapeutics (OVID): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. OVID is making an outsized move today, up 5.13% at $2.46, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Cantor Fitzgerald Initiates Coverage of Ovid Therapeutics with Overweight Rating", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology